Covered recipient · General Payments record
MARK PREBONICH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2024
$571.66
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $476.60 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $94.34 | 4 |
| Lilly USA, LLC | $89.74 | 5 |
| Exact Sciences Corporation | $62.01 | 2 |
| Mozarc Medical US LLC | $41.36 | 1 |
| Novo Nordisk AS | $37.64 | 2 |
| Inari Medical, Inc. | $34.22 | 2 |
| GlaxoSmithKline, LLC. | $33.31 | 2 |
| Janssen Pharmaceuticals, Inc | $25.14 | 1 |
| PFIZER INC. | $21.80 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.88 | 1 |
| Abbott Laboratories | $17.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.16 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125333236 | CMS |
| ABBVIE INC. | $20.16 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105309498 | CMS |
| ABBVIE INC. | $21.75 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105309502 | CMS |
| ABBVIE INC. | $25.75 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105309506 | CMS |
| ABBVIE INC. | $26.68 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105309509 | CMS |
| Exact Sciences Corporation | $31.12 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114840610 | CMS |
| Exact Sciences Corporation | $30.89 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114840616 | CMS |
| GlaxoSmithKline, LLC. | $14.22 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116636408 | CMS |
| GlaxoSmithKline, LLC. | $19.09 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116412637 | CMS |
| Inari Medical, Inc. | $16.92 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140156859 | CMS |
| Inari Medical, Inc. | $17.30 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140156861 | CMS |
| Janssen Pharmaceuticals, Inc | $25.14 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077975766 | CMS |
| Lilly USA, LLC | $17.90 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135154110 | CMS |
| Lilly USA, LLC | $13.29 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135151010 | CMS |
| Lilly USA, LLC | $21.23 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135113890 | CMS |
| Lilly USA, LLC | $16.89 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135113892 | CMS |
| Lilly USA, LLC | $20.43 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135167104 | CMS |
| Mozarc Medical US LLC | $41.36 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141013691 | CMS |
| Novartis Pharmaceuticals Corporation | $19.88 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087337891 | CMS |
| Novo Nordisk Inc | $15.41 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097802631 | CMS |
| Novo Nordisk Inc | $22.23 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096884980 | CMS |
| PFIZER INC. | $21.80 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131825794 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.